About Us
Overview
Jubilant Ingrevia Limited is a leading solutions provider of Specialty Chemicals & CDMO globally, serving Pharmaceutical, Nutrition, Agrochemical, Consumer, Semiconductor and Industrial customers. It offers customised solutions that are innovative, cost-effective and conform to global quality standards and has a broad portfolio of 130+ products.
It has over 45 years of legacy in the chemicals industry and is amongst the top players globally in Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin-B3 and many other products. Jubilant Ingrevia Limited has a fast-growing Custom Development and Manufacturing business (CDMO) serving pharmaceuticals, agrochemicals and semiconductor sectors. The Company serves customers in US, EU, Japan, Middle East, South East Asia and other geographies, in addition to domestic market from its 50+ plants across 6 manufacturing facilities in India with a workforce of over 2,300 employees. Its three R&D centres employ 150 scientists working on cutting-edge research and innovation.
Jubilant Ingrevia Limited is a Responsible Care certified company and ranked highly in global ESG indices such as Ecovadis and Dow Jones Sustainability Index. In 2024, Jubilant Ingrevia Limited was also recognised by the World Economic Forum (WEF) and entered its prestigious Global Lighthouse Network (GLN) for deployment of 4IR technologies.
It has over 45 years of legacy in the chemicals industry and is amongst the top players globally in Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin-B3 and many other products. Jubilant Ingrevia Limited has a fast-growing Custom Development and Manufacturing business (CDMO) serving pharmaceuticals, agrochemicals and semiconductor sectors. The Company serves customers in US, EU, Japan, Middle East, South East Asia and other geographies, in addition to domestic market from its 50+ plants across 6 manufacturing facilities in India with a workforce of over 2,300 employees. Its three R&D centres employ 150 scientists working on cutting-edge research and innovation.
Jubilant Ingrevia Limited is a Responsible Care certified company and ranked highly in global ESG indices such as Ecovadis and Dow Jones Sustainability Index. In 2024, Jubilant Ingrevia Limited was also recognised by the World Economic Forum (WEF) and entered its prestigious Global Lighthouse Network (GLN) for deployment of 4IR technologies.
-1f32e2de-fa3a-4294-8bc4-b40801efcf0a.jpg)
30+ Active CDMO programs across pharmaceuticals, agrochemicals, semiconductor, cosmetics & nutrition
100+ Opportunities in pipeline in CDMO & Specialty Chemicals
55 solutions in R&D pipeline; 20 of them to be commercialised by next year
Supporting innovators in pharmaceuticals, agrochemicals, semiconductor, cosmetics & nutrition
Global Leader in Bio-pyridine, 36 Pyridine derivatives. Globally #2 in Vitamin B3 & in Acetic Anhydride Merchant Market

Our Purpose, Vision, and Values
Purpose
Enable a Sustainable World through Chemistry
Vision
Be a leading provider of innovative solutions in our core chemistries globally
Promise
Caring, Sharing, Growing
We will, with utmost care for the environment and society, continue to enhance value for our customers by providing innovative products and economically efficient solutions; and for our stakeholders through growth, cost effectiveness and wise investment of resources.
Values
Values

Inspire

Challenge

Innovate

Excel

Collaborate
Legacy and Heritage
Jubilant Ingrevia’s legacy is rooted in the Life Science Ingredients (LSI) business of Jubilant Life Sciences, a franchise that has spent decades building deep chemistry capabilities, integrated manufacturing and long-standing relationships with global innovators. When the LSI business was demerged to form Jubilant Ingrevia Limited, we inherited this rich foundation and evolved it into a globally integrated specialty chemicals company serving pharmaceuticals, nutrition, agrochemicals, personal care, semiconductor, industrial chemicals and performance materials.
Ingrevia is born out of a union of ‘Ingredients’ and ‘Life’ (‘Vie’ in French). Over the years, our chemistries, manufacturing sites and R&D centres have grown in scale and sophistication. Today, our three synergistic verticals – Specialty Chemicals, Nutrition and Chemical Intermediates – are supported by backward-integrated value chains, advanced process technologies and a strong sustainability mindset. Our leadership in pyridine and its key derivatives, our positions in Vitamin B3 and Vitamin B4, and our expanding diketene derivatives platform reflect decades of process innovation and regulatory discipline, positioning us as a trusted partner across regulated and consumer markets. We are the partner of choice for 12 of the world’s top 20 pharmaceutical companies and 6 of the world’s top agrochemical companies .
At the same time, our legacy is not static. Through continued investment in R&D, digitalisation and responsible operations, we are reshaping our portfolio towards higher-value, service-led offerings such as CDMO for pharmaceuticals, agrochemicals and semiconductors, while reinforcing our long-standing strengths in integrated intermediates and nutrition.
Ingrevia is born out of a union of ‘Ingredients’ and ‘Life’ (‘Vie’ in French). Over the years, our chemistries, manufacturing sites and R&D centres have grown in scale and sophistication. Today, our three synergistic verticals – Specialty Chemicals, Nutrition and Chemical Intermediates – are supported by backward-integrated value chains, advanced process technologies and a strong sustainability mindset. Our leadership in pyridine and its key derivatives, our positions in Vitamin B3 and Vitamin B4, and our expanding diketene derivatives platform reflect decades of process innovation and regulatory discipline, positioning us as a trusted partner across regulated and consumer markets. We are the partner of choice for 12 of the world’s top 20 pharmaceutical companies and 6 of the world’s top agrochemical companies .
At the same time, our legacy is not static. Through continued investment in R&D, digitalisation and responsible operations, we are reshaping our portfolio towards higher-value, service-led offerings such as CDMO for pharmaceuticals, agrochemicals and semiconductors, while reinforcing our long-standing strengths in integrated intermediates and nutrition.
Foundation Timeline
1978–1990
Origin
- Started as VAM Organics
- Focused on VAM, Acetic Acid & Acetic Anhydride
1990–2000s
Expansion & Diversification
- Foray into Pyridine Chemistry
- Expansion of Acetyls Business
2011–2023
Forward Integration
- Forward integration into Pyridine derivatives
- Launch of Nutrition business (Vit B3)
2023 Onwards
Transformation into Specialty Leader
- Expansion of Pyridine derivatives
- Foray into Diketene derivatives
- Focus on CDMO (Agro, Pharma, Semi-Con)
- Specialty products in Nutrition (Cosmetic B3, Food B3, Choline Salts etc.)
About Jubilant Bhartia Group
Jubilant Bhartia Group is a USD multi‐billion global conglomerate with global presence in diverse sectors like Pharmaceuticals, Chemicals, Food Service (QSR) and Auto Retail. With 56,000 global workforce and presence in 80+ countries, the Jubilant Bhartia Group has four listed companies on the India Stock Exchanges. The Group prioritises Environment, Social and Governance (ESG), use of renewable energy and digitisation at the core of their operations. Jubilant Bhartia Foundation, the CSR arm of the Group, is deeply committed to Corporate Social Responsibility, focused towards Primary Education, Healthcare, Skills and Community Development and Social Entrepreneurship.
To learn more about the Jubilant Bhartia Group Click here
To learn more about the Jubilant Bhartia Group Click here